TITLE

Burden of disease due to cancer in Spain

AUTHOR(S)
de Larrea-Baz, Nerea Fernández; Álvarez-Martín, Elena; Morant-Ginestar, Consuelo; Gènova-Maleras, Ricard; Gil, Ángel; Pérez-Gómez, Beatriz; López-Abente, Gonzalo
PUB. DATE
January 2009
SOURCE
BMC Public Health;2009, Vol. 9 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Burden of disease is a joint measure of mortality and morbidity which makes it easier to compare health problems in which these two components enjoy different degrees of relative importance. The objective of this study is ascertaining the burden of disease due to cancer in Spain via the calculation of disability-adjusted life years (DALYs). Methods: DALYs are the sum of years of life lost due to premature mortality and years lost due to disability. World Health Organization methodology and the following sources of data were used: the Mortality Register and Princeton Model Life Table for Years of life lost due to premature mortality and population, incidence estimates (Spanish tumour registries and fitting of generalized linear mixed models), duration (from data of survival in Spain from the EUROCARE-3 study and fitting of Weibull distribution function) and disability (weights published in the literature) for Years lost due to disability. Results: There were 828,997 DALYs due to cancer (20.5 DALYs/1,000 population), 61% in men. Of the total, 51% corresponded to lung, colorectal, breast, stomach and prostate cancers. Mortality (84% of DALYs) predominated over disability. Subjects aged under 20 years accounted for 1.6% and those aged over 70 years accounted for 30.1% of DALYs. Conclusion: Lung, colorectal and breast cancers are responsible for the highest number of DALYs in Spain. Even if the burden of disease due to cancer is predominantly caused by mortality, some cancers have a significant weight of disability. Information on 2000 burden of disease due to cancer can be useful to assess how it has evolved over time and the impact of medical advances on it in terms of mortality and disability.
ACCESSION #
43226908

 

Related Articles

  • Going the distance. Prue, Gillian; Santin, Olinda // Cancer Nursing Practice;Nov2013, Vol. 12 Issue 9, p12 

    The authors discusses how to improve the quality of life for people with cancer. The authors say that the National Cancer Survivorship Initiative (NCSI) has been created to help those people living with cancer through its "recovery package" programme. They note that self-management programme is...

  • Cancer had negative impact on quality of life for older Americans.  // Hem/Onc Today;7/10/2009, Vol. 10 Issue 13, p28 

    The article deals with a study which examined the impact of cancer on quality of life in older patients.

  • Quality of life in cancer trials. Brinkley, Diana // British Medical Journal (Clinical Research Edition);9/14/1985, Vol. 291 Issue 6497, p685 

    Focuses on the quality of the patient's life in cancer trials. Use of palliative treatments to relieve distressing symptoms; Assessment on the side effects and the general effects on the patients life; Need for awareness and concern on the part of the clinician.

  • Quality of life in long-term survivors of adult-onset cancers. Muraoka, Miles Y.; Gotay, Carolyn Cook // JNCI: Journal of the National Cancer Institute;05/06/98, Vol. 90 Issue 9, p656 

    Presents information in relation to the quality of life in long-term cancer survivors. Details on concerns of the survivors; Evaluation of published studies; Speculation of the efficiency of the studies; Results of the studies. INSET: Carolyn Cook Gotay.

  • How Problematic Are Various Aspects of Quality of Life in Patients With Cancer at the End of Life? McMillan, Susan C.; Weitzner, Michael // Oncology Nursing Forum;Jun2000, Vol. 27 Issue 5, p817 

    Deals with a study which examined aspects of quality of life in cancer patients receiving end-of-life care that are most and least problematic for patients. Methods; Results; Discussion.

  • Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy. Demetri, G.D. // British Journal of Cancer;4/1/2001 Supplement 1, Vol. 84, p31 

    Anaemia is a common occurrence in patients with cancer and contributes to the clinical symptomatology and reduced quality of life (QOL) seen in cancer patients. Many aspects of reduced QOL, including fatigue, are known to be associated with suboptimally low levels of haemoglobin. Even...

  • Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. Sneeuw, K C A; Aaronson, N K; Sprangers, M A G; Detmar, S B; Wever, L D V; Schornagel, J H // British Journal of Cancer;9/1/99, Vol. 81 Issue 1, p87 

    This study examined the usefulness of caregiver ratings of cancer patients' quality of life (QOL), an issue of relevance to both adequate patient care and to the possible use of proxy QOL raters in clinical seudiespared QOL ratings of 90 cancer patients receiving inpatient chemotherapy with...

  • Improving cancer patients' quality of life.  // Drug Topics;8/18/2003, Vol. 147 Issue 16, p7 

    Reports on the U.S. National Institutes of Health's statement addressing growing concern about the quality of life of cancer patients.

  • Quality of life adds a human dimension to studies on treatment cost-effectiveness. Reynolds, Tom // JNCI: Journal of the National Cancer Institute;5/4/94, Vol. 86 Issue 9, p661 

    Part II. Highlights research on medical treatment cost-effectiveness and the corresponding effect of treatment on cancer patients' quality of life. Time spent in relapse; Discomforts arising from toxicities of cancer treatments.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics